The IHC ER, PR, HER2NEU, and Ki67 test is a comprehensive panel performed at DNA Labs UAE, designed to evaluate the presence and extent of specific biomarkers in breast cancer tumors. This test plays a crucial role in the diagnosis, treatment planning, and prognosis of breast cancer. Here's a brief overview of each component:
- **ER (Estrogen Receptor):** Tests for the presence of estrogen receptors in the cancer cells. Positive results indicate that the cancer may respond to hormonal therapies.
- **PR (Progesterone Receptor):** Similar to ER, this tests for the presence of progesterone receptors. ER and PR statuses together help in determining the hormone responsiveness of the tumor.
- **HER2NEU (Human Epidermal Growth Factor Receptor 2):** Assesses the overexpression of the HER2 protein on the surface of cancer cells, which is associated with more aggressive growth. HER2-positive cancers may be treated with targeted therapies.
- **Ki67:** This marker is used to determine the proliferation rate of cancer cells, indicating how quickly the cancer is likely to grow and spread.
At DNA Labs UAE, this panel is offered at a cost of 1800 AED. The results from this test are pivotal for clinicians in making informed decisions regarding the most effective treatment strategies for breast cancer patients, tailored to the molecular profile of their tumors.
The IRF4/MUM1 test is a specialized diagnostic assessment aimed at detecting the presence of the IRF4 (Interferon Regulatory Factor 4) or MUM1 (Multiple Myeloma Oncogene 1) gene rearrangements. These genetic markers are crucial for the diagnosis and prognosis of certain lymphoid cancers, including multiple myeloma and some types of non-Hodgkin lymphoma. The test is conducted through sophisticated molecular techniques to identify these specific genetic alterations, which can guide treatment decisions and provide valuable information about the patient's disease progression.
At DNA Labs UAE, the IRF4/MUM1 test is available for a cost of 1800 AED. The laboratory is equipped with state-of-the-art technology and staffed by experienced professionals to ensure accurate and reliable results. Patients or healthcare providers looking to perform the IRF4/MUM1 test can expect a high standard of service, with results that contribute significantly to the personalized care and management of lymphoid malignancies.
The "Jak 2 Mutation Detection Panel Exons 12 Test" is a specialized diagnostic assessment designed to identify mutations in the exon 12 region of the Janus kinase 2 (JAK2) gene. These mutations are often associated with certain types of blood disorders, including myeloproliferative neoplasms (MPNs) such as polycythemia vera, essential thrombocythemia, and primary myelofibrosis. The test plays a critical role in the diagnosis and management of these conditions, enabling healthcare providers to tailor treatment plans more effectively.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test involves a blood sample from the patient. The laboratory utilizes state-of-the-art molecular techniques to analyze the exon 12 region of the JAK2 gene for any mutations that may be present. This precise approach ensures high accuracy and reliability of the results.
The cost of the Jak 2 Mutation Detection Panel Exons 12 Test at DNA Labs UAE is set at 1800 AED. This price reflects the sophisticated nature of the testing process and the valuable insights it provides for patient care. Patients or healthcare providers interested in this test should contact DNA Labs UAE for further information on the procedure and any preparatory steps required before testing.
The "Jak 2 Mutation Detection Panel Exons 12-15 Test" is a specialized diagnostic procedure aimed at identifying mutations within exons 12 to 15 of the Janus kinase 2 (JAK2) gene. This gene plays a crucial role in the signaling pathways that regulate blood cell production in the bone marrow. Mutations in these specific exons are associated with a range of myeloproliferative neoplasms (MPNs), which are a group of blood cancers characterized by the overproduction of one or more types of blood cells. These mutations can lead to conditions such as polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
The test is performed at DNA Labs UAE, a state-of-the-art facility known for its advanced genetic testing capabilities. By analyzing a sample of the patient's blood or bone marrow, the lab can detect the presence of mutations in the JAK2 gene, providing crucial information for the diagnosis, prognosis, and treatment planning of MPNs.
The cost of the "Jak 2 Mutation Detection Panel Exons 12-15 Test" at DNA Labs UAE is 1800 AED. This investment in testing is vital for individuals at risk of or suspected to have MPNs, as early detection and precise identification of the specific mutation can significantly impact the management and outcome of these conditions.
The "Large Biopsy 7 Test" offered by DNA Labs UAE is a comprehensive diagnostic examination designed to analyze large biopsy samples for a variety of conditions or abnormalities. This test is particularly important in the fields of oncology and pathology, where it aids in the detection, classification, and understanding of various types of tumors or lesions. By examining a large sample of tissue, pathologists can provide more accurate diagnoses, assess the extent of disease, and recommend appropriate treatment options. The test cost is set at 1800 AED, reflecting the sophisticated techniques and expert analysis involved in processing and interpreting the biopsy samples. DNA Labs UAE is known for its state-of-the-art facilities and commitment to providing precise and timely diagnostic services, making it a trusted choice for patients and healthcare providers seeking detailed biopsy analysis.
The MDM2 Test, available at DNA Labs UAE for a cost of 1800 AED, is a specialized genetic analysis designed to identify amplifications or overexpression of the MDM2 gene. This gene plays a critical role in regulating the tumor suppressor protein p53, which helps control cell division and growth. Alterations in the MDM2 gene can disrupt this balance, potentially leading to uncontrolled cell growth and cancer development. The test is particularly relevant in the diagnosis and management of certain cancers, such as sarcomas, where MDM2 gene amplification may be present. By providing precise genetic information, the MDM2 Test aids healthcare professionals in making informed decisions regarding prognosis, treatment options, and personalized medicine approaches for patients facing cancer diagnoses.
The MET Amplification NSCLC Test is a specialized diagnostic procedure designed to identify the amplification of the MET gene in patients with non-small cell lung cancer (NSCLC). This genetic alteration can influence tumor growth and spread, making it a critical target for personalized cancer therapy. The test is performed on a sample of the tumor tissue to detect the presence and extent of MET gene amplification, which can guide oncologists in tailoring the most effective treatment plans for their patients.
Administered at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test employs advanced genomic technologies to ensure precise and reliable results. With a focus on providing comprehensive support for cancer management, DNA Labs UAE offers this test at a cost of 1800 AED. The investment in such a test is crucial for patients with NSCLC, as it opens the door to targeted therapies that can significantly improve treatment outcomes and quality of life.
The MLC1 Gene Mutation Analysis, also known as the Agrawal Mutation Test, is a specialized genetic test conducted to identify mutations in the MLC1 gene, which are associated with various neurological conditions. This test plays a critical role in the diagnosis and management of diseases related to MLC1 gene mutations, enabling healthcare professionals to tailor treatments based on the specific genetic makeup of an individual. The test cost is set at 1800 AED and is available at DNA Labs UAE, a leading facility equipped with state-of-the-art technology for genetic testing and analysis. By providing accurate and reliable results, DNA Labs UAE aids in the early detection and intervention of conditions linked to MLC1 gene mutations, ultimately contributing to better patient outcomes.
The MYD88 Gene Mutation Analysis Test is a specialized diagnostic procedure aimed at identifying mutations within the MYD88 gene, a critical component in the immune response and signaling pathways within cells. This test is particularly relevant for patients suspected of having conditions that are linked to MYD88 mutations, such as certain types of lymphomas and other hematological malignancies. By analyzing the genetic material extracted from a patient's blood or tissue sample, this test can pinpoint specific alterations in the MYD88 gene that may contribute to disease pathogenesis or influence treatment strategies.
Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, the MYD88 Gene Mutation Analysis Test is priced at 1800 AED. This cost reflects the comprehensive nature of the analysis, including the sophisticated technology and expert interpretation involved in identifying and understanding the implications of MYD88 gene mutations. For patients and healthcare providers, the results of this test can be invaluable in guiding clinical decisions, tailoring personalized treatment plans, and ultimately improving patient outcomes.
The N-Myc Oncogene Test is a sophisticated diagnostic procedure aimed at detecting amplifications or abnormalities in the N-Myc gene, which is often associated with various types of cancer, including neuroblastoma, a common cancer in children that affects the nerve tissues. This test plays a crucial role in identifying the presence of N-Myc gene amplifications, which can influence the aggressiveness of the cancer and guide treatment decisions.
Performed at DNA Labs UAE, a state-of-the-art facility known for its advanced genetic testing capabilities, the test involves analyzing a patient's DNA sample to look for specific changes in the N-Myc oncogene. These insights are invaluable for oncologists in determining the prognosis of the disease and tailoring personalized treatment plans that can significantly improve patient outcomes.
The cost of the N-Myc Oncogene Test at DNA Labs UAE is set at 1800 AED. While the price might seem significant, the value it provides in terms of precise diagnosis and guiding effective treatment strategies is invaluable for patients facing cancers associated with N-Myc gene alterations.
